ArticleScientific reports2021

Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.

Marc Hasenfratz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.